Effectiveness and safety of the available preventive tuberculosis treatment regimens for children and adolescents: systematic review and network meta-analysis - Scorecard - MDSpire
Clinical Scorecard: Efficacy and Safety of Current Preventive Treatment Options for Tuberculosis in Pediatric Populations: A Systematic Review and Network Meta-Analysis
At a Glance
Category
Detail
Condition
Tuberculosis Infection in Pediatric Populations
Key Mechanisms
Comparison of preventive treatment regimens for effectiveness and safety in children and adolescents exposed to drug-susceptible TB.
Target Population
Children and adolescents younger than 18 years without HIV.
Care Setting
Pediatric tuberculosis management
Key Highlights
Short-course regimens (3HP, 4HR, 4R) may improve adherence compared to 9H.
4HR and 3HR may lower active TB incidence at 2 years.
4R is associated with fewer adverse reactions compared to 9H.
Guideline-Based Recommendations
Diagnosis
Diagnosis of tuberculosis infection should be prioritized in pediatric populations.
Management
Consider short-course regimens for tuberculosis preventive treatment in children.
Monitoring & Follow-up
Monitor for adverse reactions during tuberculosis preventive treatment.
Risks
Children face a higher risk of progression to active TB disease without preventive treatment.
Patient & Prescribing Data
Pediatric patients exposed to drug-susceptible TB.
Short-course regimens may enhance treatment adherence and reduce active TB incidence.
Clinical Best Practices
Implement short-course tuberculosis preventive treatment regimens in pediatric patients.
Conduct further high-quality trials in younger children to inform guidelines.
